Abie Ekangaki

Senior Vice President and Global Head, Biotech R&D Solutions

Abie brings more than 30 years of experience in pharma, biotechnology, and clinical research organizations around the world to his role at Cytel. He is recognized for helping sponsors optimize development programs through innovative clinical trial design, statistical strategy, and operational excellence.

Throughout his career, Abie has developed deep expertise in biostatistics, adaptive and advanced trial designs, regulatory strategy, and the execution of complex global clinical programs. He has advised development teams across a broad range of therapeutic areas, including immunology, oncology, neuroscience, endocrinology, and rare diseases. He has also served on independent Data Monitoring Committees and supported regulatory interactions with health authorities.

Before joining Cytel, Abie held senior leadership positions at Premier Research, UCB BioPharma, Quintiles (now IQVIA), and Eli Lilly, where he led global biometrics and statistical sciences organizations and supported pivotal development programs across all phases of clinical research.

Abie is an active leader in the statistical community, where he has served as an At-Large Advisor to the Executive Steering Committee of the American Statistical Association’s Biopharmaceutical Section (BIOP), as well as a designated BIOP mentor to emerging statisticians and data scientists. He holds a PhD and MSc in Biostatistics from the University of Southampton, a Mini-MBA in BioPharma Innovation from Rutgers Business School, and a BSc in Mathematics with Statistics from the University of Lagos.